Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
1600000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of share acquisition rights as stock options
発行・処分する株式数
1,000 shares per share acquisition right; maximum of 1,600 rights and 1.6 million shares
Intended allottee
Category Executive directors, executive officers, persons equivalent thereto, and employees of the Company and its subsidiaries / Number of Shares Not disclosed
The share acquisition rights will be issued without consideration. The exercise price per share will be the higher of the average closing price for the month preceding the month in which the allotment date falls and the closing price on the allotment date, multiplied by 1.05.
発行済株式総数
Approximately 0.61% of the total number of issued shares (maximum)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The initial exercise price calculated using the above method. Adjustment provisions apply in the event of a share split, share consolidation, issuance below market value, or similar event. The lower limit of any adjustment is Not disclosed.
Exercise period
Seven years from 1 day of the month following the month containing the date on which 2 years have elapsed from the allotment date of the share acquisition rights.
Number of Stock Acquisition Rights
Maximum total issuance of 1,600 share acquisition rights. The number of unexercised rights remaining is Not disclosed.
Reason for acquisition without consideration
If the share acquisition rights cease to be succeeded to in connection with a corporate reorganization, the Company may acquire them without consideration on a date separately determined by the Company's Board of Directors.
Categories and Number of Persons Covered
Executive directors, executive officers, persons equivalent thereto, and employees of the Company and its subsidiaries. The number of recipients and the number of shares allotted by category are Not disclosed.
Basis for determining the amount to be paid
The higher of the average closing price on each trading day in the month preceding the month in which the allotment date falls and the closing price on the allotment date, multiplied by 1.05 (a 5% premium).
Procedures under the Corporate Code of Conduct
To be submitted to the Company's 114th Annual General Meeting of Shareholders, scheduled for 25 June 2026
Impact on Business Performance
The purpose is to improve the performance of the Group as a whole and consolidated performance.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of share acquisition rights as stock options |
| Number of shares to be issued or disposed of | 1,000 shares per share acquisition right; maximum of 1,600 rights and 1.6 million shares |
| Issue price and disposal price | The share acquisition rights will be issued without consideration. The exercise price per share will be the higher of the average closing price for the month preceding the month in which the allotment date falls and the closing price on the allotment date, multiplied by 1.05. |
| Intended allottee | Category Executive directors, executive officers, persons equivalent thereto, and employees of the Company and its subsidiaries / Number of Shares Not disclosed |
| Dilution Rate | Approximately 0.61% of the total number of issued shares (maximum) |
| Basis for determining the amount to be paid | The higher of the average closing price on each trading day in the month preceding the month in which the allotment date falls and the closing price on the allotment date, multiplied by 1.05 (a 5% premium). |
| Exercise price | The initial exercise price calculated using the above method. Adjustment provisions apply in the event of a share split, share consolidation, issuance below market value, or similar event. The lower limit of any adjustment is Not disclosed. |
| Exercise period | Seven years from 1 day of the month following the month containing the date on which 2 years have elapsed from the allotment date of the share acquisition rights. |
| Number of Stock Acquisition Rights | Maximum total issuance of 1,600 share acquisition rights. The number of unexercised rights remaining is Not disclosed. |
| Reason for acquisition without consideration | If the share acquisition rights cease to be succeeded to in connection with a corporate reorganization, the Company may acquire them without consideration on a date separately determined by the Company's Board of Directors. |
| Categories and Number of Persons Covered | Executive directors, executive officers, persons equivalent thereto, and employees of the Company and its subsidiaries. The number of recipients and the number of shares allotted by category are Not disclosed. |
| Procedures under the Corporate Code of Conduct | To be submitted to the Company's 114th Annual General Meeting of Shareholders, scheduled for 25 June 2026 |
| Impact on Business Performance | The purpose is to improve the performance of the Group as a whole and consolidated performance. |
Items this document does not state (15)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To align the interests of the eligible recipients with those of shareholders, provide them with a shared incentive to improve the performance of the Group as a whole, and improve consolidated performance.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.